PwC Opens Google Cloud AI Experience Zones to Feature Solutions Powered by Google Cloud’s Generative AI
PwC today announced the opening of its first Google Cloud AI Experience Zone at the firm’s US Acceleration Center in Bengaluru, India. It also announced additional, near-term planned openings of Google Cloud AI Experience Zones in Boston, MA and San Francisco, CA. At each, PwC will invite clients to get hands-on experience with existing, next-gen solutions, powered by Google Cloud’s AI technology, including Google Gemini models, Vertex AI and more.
“We're thrilled to deepen our alliance with Google Cloud and harness its groundbreaking AI capabilities in this innovative space,” said Jason Ruge, Partner, US Google Cloud Alliance Leader, PwC US. “These Google Cloud AI Experience Zones will help showcase how PwC’s industry-specific solutions built on Google Cloud technology, including Vertex AI and Gemini, can revolutionize digital and business transformations for our customers.”
PwC’s leading industry capabilities enable business model reinvention and help companies transform their business, enhance productivity and maintain regulatory compliance. These Google Cloud AI Experience Zones give customers a space to engage with agentic workflows in which AI seamlessly performs work in concert with humans to solve industry-specific challenges. PwC’s suite of offerings spans various industries and includes:
- Health AI industry solutions: Our Healthcare Agent Hub helps reduce the workload of clinicians so that they can focus on patient care. They also enable preventive care, drug discovery and clinical trials.
- Generative AI (GenAI) capabilities powered by our GenAI Agent & Platform: GenAI conversational agents are tailored for each industry and functional use case to help improve productivity, creative content creation, personalization and user experience.
- Data marketplace capabilities: This solution removes data silos and democratizes enterprise data, enabling data commercialization to deliver value to businesses.
- Retail experience capabilities powered by Retail Search & GenAI: This intuitive portal serves actionable insights, enables faster execution, helps reduce response time and forecasts demand.
According to PwC’s 2024 Cloud and AI Business Survey, the ability to leverage AI is the top driver of increased cloud budgets. As AI becomes intrinsic to how companies do business, next-generation cloud architectures that take advantage of the latest AI capabilities are fueling modern business strategies. PwC looks to leverage its alliance relationships with leading enterprise cloud vendors like Google Cloud that are continually integrating AI capabilities into their products to deliver transformative outcomes built on trust and powered by data.
PwC’s strategic alliance with Google Cloud blends innovative thinking and focused experience to unlock the full potential of cloud. With PwC’s continued focus and investment in expanding its Google Cloud L400 GenAI experience, the Firm is positioned to help clients achieve their GenAI goals and deliver the digital insights and transformative outcomes they seek.
“Hardwiring trust through business is the foundation for accelerating what you can do,” said Dallas Dolen, Global Google Alliance Leader and Technology, Media and Telecommunications Industry Leader, PwC US. “Through our alliance with Google Cloud, we’re helping deliver even greater value to companies’ cloud investments and bringing fresh, holistic, connected thinking to build and keep trust.”
Earlier this year, PwC announced collaborations with Google Cloud to help customers realize value from their GenAI investments.
“Generative AI is poised to redefine entire industries and shape the future of business,” said Victor Morales, Vice President of Global System Integrators Partnerships at Google Cloud. “Our continued partnership with PwC will help customers harness the full potential of generative AI, providing them with the expertise and tools they need to innovate, optimize and achieve their business goals.”
You can also explore how PwC AI-enabled ESG solutions can help you contribute positive impact to the environment while improving efficiency and staying compliant.
Additionally, these Google Cloud AI Experience Zones will serve as collaborative hubs to brainstorm with clients to explore the “art of the possible” to help unlock new potential enabling business model reinvention. Clients will be able to leverage this space to explore advanced solutions and experimentation with Google beta offerings to stay ahead on technological advancement.
About PwC
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 149 countries with over 370,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241121261817/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline4.9.2025 07:00:00 CEST | Press release
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II and VIB. Validation of Leadership Position in Microbiome-Based Therapeutics Proceeds will enable MRM Heal
Abbove Unveils “Mia”: Opening a New Chapter in Digital Wealth Planning in Europe4.9.2025 06:00:00 CEST | Press release
Artificial Intelligence at the service of wealth advisors and their clients Abbove, the European platform for collaborative and family-centered wealth planning, announces today the launch of Mia, its new artificial intelligence agent. Used by more than 1,100 advisors and deployed to over 37,000 families across Europe, Abbove takes a major step forward in its mission to reimagine the wealth advisory experience in the digital age. Designed to enhance the capabilities of wealth advisors, family officers, and financial experts, Mia acts as an intelligent co-pilot. It simplifies the reading and analysis of complex estate documents, automatically extracts key information, and assists users in the understanding, enrichment, and structuring of wealth data. “The launch of Mia opens an entirely new functional AI vertical on our platform, unlocking near-infinite possibilities for future development. It’s a key milestone that brings us closer to our ambition of becoming the leading pan-European we
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions4.9.2025 02:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903434045/en/ Under the terms of the agreement, Biocytogen will provide proprietary, fully human antibodies derived from its RenMice® platform for evaluation in Merck KGaA, Darmstadt, Germany’s antibody-conjugated LNP services. Merck KGaA, Darmstadt, Germany has been granted an exclusive option to acquire rights to selected antibody assets in return for fees and royalties on sales and su
OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir
BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release
BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom